Among patients with moderate peripheral artery disease, GLP-1 use was associated with reduced risk for cardiovascular and ...

Delays in phlebitis care can lead to serious complications, and nurses and doctors must act quickly with clear plans to ...

With a distribution agreement in place and an option to acquire Contego Medical, Medtronic’s peripheral vascular division ki ...

The 26th annual New Cardiovascular Horizons (NCVH) conference brought 1,400 from across the globe to New Orleans to ...

A new statement from leading heart and blood vessel experts in Europe is providing clinical guidance for treatments to ...

Embolization, Inc., a medical device company based in Boulder, Colorado, announced its nitinol-enhanced device (NED) has ...

Dr. Greg Vigna, national PICC line attorney, states,“Peripheral vein catheters can cause pain with varying degrees of inflammation at the implantation site due to mechanical and immunologic ...

Like in the STRIDE study of PAD, GLP-1s improved outcomes, but more work is needed to clarify who may benefit most.

Modern vascular centres use sophisticated, painless tests in their vascular labs to detect even early signs of poor circulation. Written by : Sushmita Sharma Updated at: May 29, 2025 16:10 IST ...

Semaglutide 1 mg improves walking distance in patients with early peripheral artery disease and type 2 diabetes, regardless ...

A new statement from leading heart and blood vessel experts in Europe is providing clinical guidance for treatments to ...

Nurse practitioners are increasingly filling a gap that is expected to widen as the senior population explodes and the number ...